Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019
Journal
Archivos de Bronconeumología
ISSN
0300-2896
Date Issued
2020
Author(s)
María Montes de Oca
Maria Victorina López Varela
Agustín Acuña
Eduardo Schiavi
Alejandro Casas
Antonio Tokumoto
Carlos A. Torres Duque
Alejandra Ramírez-Venegas
Gabriel García
Aquiles Camelier
Miguel Bergna
Mark Cohen
Efraín Sanchez-Angarita
Santiago Guzmán
Manuel Barros
Alejandra Rey
Type
Resource Types::text::journal::journal article
Subjects
chronic obstructive pulmonary disease
;
copd
;
inhaled medication
;
administration, inhalation
;
adrenergic beta-2 receptor agonists
;
humans
;
latin america
;
muscarinic antagonists
;
pulmonary disease, chronic obstructive
;
beta 2 adrenergic receptor blocking agent
;
bronchodilating agent
;
corticosteroid
;
long acting drug
;
muscarinic receptor blocking agent
;
short acting drug
;
beta 2 adrenergic receptor stimulating agent
;
muscarinic receptor blocking agent
;
bronchodilating agent
;
corticosteroid
;
ipratropium bromide
;
long acting drug
;
short acting drug
;
tiotropium bromide
;
algorithm
;
chronic obstructive lung disease
;
combination drug therapy
;
disease exacerbation
;
disease severity
;
drug safety
;
drug substitution
;
drug withdrawal
;
eosinophil count
;
evidence based medicine
;
human
;
intermethod comparison
;
latin american medicine
;
lung function
;
monotherapy
;
pneumonia
;
risk benefit analysis
;
short survey
;
side effect
;
inhalational drug administration
;
south and central america
;
article
;
disease exacerbation
;
drug use
;
pneumonia
;
risk
;
symptom